HKSE - Delayed Quote • HKD
The United Laboratories International Holdings Limited (3933.HK)
At close: April 26 at 4:08 PM GMT+8
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
13,058,861.000
11,334,262.000
9,703,438.000
8,772,488.000
Cost of Revenue
7,130,538.000
6,365,272.000
5,492,391.000
4,966,270.000
Gross Profit
5,928,323.000
4,968,990.000
4,211,047.000
3,806,218.000
Operating Expense
3,177,254.000
2,877,596.000
2,744,047.000
2,490,112.000
Operating Income
2,751,069.000
2,091,394.000
1,467,000.000
1,316,106.000
Net Non Operating Interest Income Expense
-5,872.000
-10,858.000
22,549.000
-68,485.000
Pretax Income
2,791,967.000
2,006,766.000
1,202,647.000
882,334.000
Tax Provision
556,221.000
425,743.000
213,062.000
181,416.000
Net Income Common Stockholders
2,236,073.000
1,581,094.000
988,098.000
702,989.000
Diluted NI Available to Com Stockholders
2,236,073.000
1,581,094.000
988,098.000
702,989.000
Basic EPS
1.23
0.87
0.54
0.40
Diluted EPS
1.23
0.87
0.54
0.40
Basic Average Shares
1,817,160.000
1,819,730.000
1,840,043.000
1,765,968.000
Diluted Average Shares
1,817,160.000
1,819,730.000
1,840,043.000
1,765,968.000
Total Expenses
10,307,792.000
9,242,868.000
8,236,438.000
7,456,382.000
Net Income from Continuing & Discontinued Operation
2,236,073.000
1,581,094.000
988,098.000
702,989.000
Normalized Income
2,226,773.564
1,595,349.289
1,245,603.034
977,286.578
Interest Income
92,657.000
70,737.000
82,780.000
112,788.000
Interest Expense
98,529.000
81,595.000
60,231.000
181,273.000
Net Interest Income
-5,872.000
-10,858.000
22,549.000
-68,485.000
EBIT
2,890,496.000
2,088,361.000
1,262,878.000
1,063,607.000
EBITDA
3,453,586.000
2,640,792.000
1,883,735.000
1,678,072.000
Reconciled Cost of Revenue
7,130,538.000
6,365,272.000
5,492,391.000
4,966,270.000
Reconciled Depreciation
563,090.000
552,431.000
620,857.000
614,465.000
Net Income from Continuing Operation Net Minority Interest
2,236,073.000
1,581,094.000
988,098.000
702,989.000
Total Unusual Items Excluding Goodwill
11,613.000
-18,094.000
-312,947.000
-345,293.000
Total Unusual Items
11,613.000
-18,094.000
-312,947.000
-345,293.000
Normalized EBITDA
3,441,973.000
2,658,886.000
2,196,682.000
2,023,365.000
Tax Rate for Calcs
0.000
0.000
0.000
0.000
Tax Effect of Unusual Items
2,313.564
-3,838.711
-55,441.966
-70,995.422
12/31/2020 - 6/15/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4507.T Shionogi & Co., Ltd.
7,306.00
+2.21%
0867.HK China Medical System Holdings Limited
7.200
+1.84%
1498.HK PuraPharm Corporation Limited
0.750
0.00%
0013.HK HUTCHMED (China) Limited
30.350
0.00%
3320.HK China Resources Pharmaceutical Group Limited
5.040
+1.61%
2877.HK China Shineway Pharmaceutical Group Limited
9.600
+2.67%
1681.HK Consun Pharmaceutical Group Limited
5.670
-0.87%
3692.HK Hansoh Pharmaceutical Group Company Limited
17.220
+2.50%
INNO.CN InnoCan Pharma Corporation
0.2800
+1.82%
OGI.TO Organigram Holdings Inc.
2.5700
+0.39%